Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
NCT02510937
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Fibrosis
Interventions
DRUG:
CC-90001
Sponsor
Celgene